The Platin-X series: activation, targeting, and delivery-Reference-Cited by-同舟云学术

The Platin-X series: activation, targeting, and delivery

Published:2016 Issue:33 Volume:45 Page:12992-13004
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Basu Uttara¹²³⁴⁵,Banik Bhabatosh¹²³⁴⁵,Wen Ru¹²³⁴⁵,Pathak Rakesh K.¹²³⁴⁵,Dhar Shanta¹²³⁴⁵

Affiliation:

1. NanoTherapeutics Research Laboratory

2. Department of Chemistry

3. University of Georgia

4. Athens

5. USA

Abstract

In this review, we discuss the attempts made by our lab to develop Pt(iv) prodrugs that can be activated and delivered using targeted nanodelivery systems.

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/DT/C6DT01738J

Reference110 articles.

1. Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

2. Cellular processing of platinum anticancer drugs

3. Functionalization of Platinum Complexes for Biomedical Applications

4. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

5. Prodrugs: design and clinical applications

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanostructured mesoporous silica carriers for platinum-based conjugates with anti-inflammatory agents;Biomaterials Advances;2024-12

2. Co-targeting CDK 4/6 and C-MYC/STAT3/CCND1 axis and inhibition of tumorigenesis and epithelial-mesenchymal-transition in triple negative breast cancer by Pt(II) complexes bearing NH3 as trans-co-ligand;Journal of Inorganic Biochemistry;2024-10

3. Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP);ChemMedChem;2024-06-03

4. Pt(iv) derivatives of cisplatin and oxaliplatin bearing an EMT-related TMEM16A/COX-2-selective dual inhibitor against colorectal cancer cells HCT116;RSC Medicinal Chemistry;2024

5. Platinum(IV) Complexes as Inhibitors of STAT3 and Regulators of the Tumor Microenvironment To Control Breast Cancer;Journal of Medicinal Chemistry;2023-08-14